Adjunctive pharmacotherapy
1 paper2 findings
- 1 lab
- Humans1
Outcomes
2Time below range
no changein humans1
1 study
Time below range
no changein humans1
Adjunctive pharmacotherapy has no effect on time below range in humans (averaged 2%).
“Time below range averaged 2% and did not change.”
Humansin type 1 diabetes using open-source automated insulin delivery systems12 monthsn = 357
ADA Scientific Sessions 2026 abstract5 Jun 2026
Time in range
upin humans1
1 study
Time in range
upin humans1
Adjunctive pharmacotherapy increases time in range in humans (from 63% to 73%).
“Average Time in Range (TIR) rose from 63% at baseline to 73% at 12 months.”
Humansin type 1 diabetes using open-source automated insulin delivery systems12 monthsn = 357
ADA Scientific Sessions 2026 abstract5 Jun 2026
Latest
1 in 12 monthsADA Scientific Sessions 2026 Abstract
Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems
Cohort study of 357 peopleSGLT2 inhibitors